Skip to main content

Quinapril News

FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets Due to Potential Presence of N-Nitroso-Quinapril Impurity

Baltimore, Maryland, December 21, 2022 – Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Heart Failure, Congestive Heart Failure, High Blood Pressure, Hypertension, Left Ventricular Dysfunction

Quinapril patient information at Drugs.com